fasting on retatrutide and Intermittent Fasting: Complete 2026 Guide Exploring Retatrutide Benefits for Weight

Association between metformin and the risk of gastric cancer in patients with type 2 diabetes mellitus: a meta-analysis of cohort studies

Round-the-Clock Doctor Access Licensed providers are reachable 24/7 via messaging

The FDA warns that compounded GLP-1s can be risky

Here, this biosensor was applied to establish the L-carnitine biosynthetic pathway in E

Summary: GLP-1 receptor agonists produce modest reductions in total cholesterol, LDL cholesterol, and triglycerides, but are not licensed or recommended as primary treatments for dyslipidaemia

When I first started recommending GLP-1 agonists for weight loss back in 2016 and 2017 there was some small evidence that they were associated with thyroid cancer